FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yves Bécouarn

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Geographic Areas

France

Co-author Network

Publications

TOP 3
Sophie Gourgou-Bourgade; Rosine Guimbaud; Jean-Luc Raoul; Marc Ychou; Antoine Adenis; Caroline Bascoul-Mollevi; Yves Bécouarn; Jocelyne Bérille; Valérie Boige; Olivier Bouché; Françoise Desseigne; Thierry Conroy
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.
Dominique Béchade; Yves Bécouarn; Grégoire Désolneux; Marianne Fonck; Isabelle Soubeyran; Serge Evrard
[Regenerative nodular hyperplasia of the liver related to oxaliplatin-based chemotherapy].
Jean-Pierre Gérard; Sophie Gourgou-Bourgade; Christophe Hennequin; Béata Juzyna; Gérard Lledo; Marc-André Mahé; Isabelle Martel-Lafay; Laurent Mineur; Xavier Mirabel; Jean-François Seitz; V Vendrely; David Azria; Yves Bécouarn; Laurent Bedenne; Jean-François Berdah; Olivier Bouché; Guy de La Roche; Bernard Denis; Olivier Dupuis; Pierre-Luc Etienne; Eric François; Thierry Conroy
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yves Bécouarn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sophie Gourgou-Bourgade; Rosine Guimbaud; Jean-Luc Raoul; Marc Ychou; Antoine Adenis; Caroline Bascoul-Mollevi; Yves Bécouarn; Jocelyne Bérille; Valérie Boige; Olivier Bouché; Françoise Desseigne; Thierry Conroy
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(1):23-9.
2013: Dominique Béchade; Yves Bécouarn; Grégoire Désolneux; Marianne Fonck; Isabelle Soubeyran; Serge Evrard
[Regenerative nodular hyperplasia of the liver related to oxaliplatin-based chemotherapy].
Presse médicale (Paris, France : 1983) 2013;42(1):102-7.
2012: Jean-Pierre Gérard; Sophie Gourgou-Bourgade; Christophe Hennequin; Béata Juzyna; Gérard Lledo; Marc-André Mahé; Isabelle Martel-Lafay; Laurent Mineur; Xavier Mirabel; Jean-François Seitz; V Vendrely; David Azria; Yves Bécouarn; Laurent Bedenne; Jean-François Berdah; Olivier Bouché; Guy de La Roche; Bernard Denis; Olivier Dupuis; Pierre-Luc Etienne; Eric François; Thierry Conroy
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(36):4558-65.
2012: Simone Mathoulin-Pélissier; Elodie Pinon; Jean-Louis Renaud-Salis; Eric Rullier; Dominique Auby; Yves Bécouarn; Geneviève Belleannée; Gaëlle Coureau; Anne Jaffré
Quality indicators for colorectal cancer surgery and care according to patient-, tumor-, and hospital-related factors.
BMC cancer 2012;12():297.
2011: Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; eric assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
The New England journal of medicine 2011;364(19):1817-25.
2011: Isabelle Soubeyran; Isabelle Mahouche; Aude Grigoletto; Thierry Leste-Lasserre; Guillaume Drutel; Christophe Rey; Stephane Pedeboscq; France Blanchard; Veronique Brouste; Jean-Christophe Sabourin; Yves Bécouarn; Josy Reiffers; François Ichas; Francesca De Giorgi
Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function.
The American journal of pathology 2011;178(5):1986-98.
2010: Jean-Pierre Gérard; David Azria; Sophie Gourgou-Bourgade; Isabelle Martel-Laffay; Christophe Hennequin; Pierre-Luc Etienne; Véronique Vendrely; Eric François; Guy de La Roche; Olivier Bouché; Xavier Mirabel; Bernard Denis; Laurent Mineur; Jean-François Berdah; Marc André Mahé; Yves Bécouarn; Olivier Dupuis; Gérard Lledo; Christine Montoto-Grillot; Thierry Conroy
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1638-44.
2009: Jean Palussière; E Descat; Marianne Fonck; Françoise Bonichon; F Chomy; Yves Bécouarn; Antoine Avril; Michèle Kind; Alain Ravaud
[Radiofrequency ablation in the treatment of liver and lung tumors].
Bulletin du cancer 2009;96(11):1099-109.
2007: Yves Bécouarn; Pierre Senesse; S Thézenas; Eveline Boucher; Antoine Adenis; L Cany; Jacques-Henri Jacob; F Cvitkovic; C Montoto-Grillot; Marc Ychou
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):2000-5.
2007: Serge Evrard; Yves Bécouarn; René Brunet; Marianne Fonck; Caroline Larrue; Simone Mathoulin-Pélissier
Could bipolar vessel sealers prevent bile leaks after hepatectomy?
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2007;392(1):41-4.
2006: Pierre Senesse; Line Leichtnam-Dugarin; Yves Bécouarn; Pierre Bey; Sylvie Brusco; Julien Carretier; Valérie Delavigne; Françoise Desseigne; Jean-Bernard Dubois; Michel Ducreux; Serge Evrard; Béatrice Fervers; Jean-Pierre Gérard; Marc Giovannini; Hélène Hoarau; Pierre Lasser; Pierre Meeus; Thierry Philip; Michel Rivoire; Patricia Ponseda; Philippe Rouanet; Eliane Toureille; Jean-Jacques Voigt
[Rectal cancer Information dedicated to cancer patients and relatives].
Bulletin du cancer 2006;93(2):179-91.
2005: Yves Bécouarn; Anne Rullier; Philippe Gorry; Denis Smith; Bruno Richard-Molard; Emmanuel Echinard; Patrick Texereau; Richard Beyssac; Jean-Louis Legoux; Hervé Lamouliatte; Thierry Frebourg; Sylviane Olschwang; Brigitte Gilbert; Laurence Venat; Véronique Picot; François Paraf; Michel Longy
Value of microsatellite instability typing in detecting hereditary non-polyposis colorectal cancer. A prospective multicentric study by the Association Aquitaine Gastro.
Gastroentérologie clinique et biologique 2005;29(6-7):667-75.
2004: Thierry Conroy; Guillaume Gory-Delabaere; Antoine Adenis; Lise Bosquet; Olivier Bouché; Christophe Louvet; Emmanuel Mitry; Yves Bécouarn; Jean-François Bosset; Michel Ducreux; Pierre-Luc Etienne; Yacine Merrouche; Geneviève Monges; Philippe Rougier
[Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)].
Bulletin du cancer 2004;91(10):759-68.
2001: Yves Bécouarn; C Agostini; Nathalie Trufflandier; V Boulanger
Oxaliplatin: available data in non-colorectal gastrointestinal malignancies.
Critical reviews in oncology/hematology 2001;40(3):265-72.
2001: Yves Bécouarn; E Gamelin; Bruno Coudert; Sylvie Négrier; J Y Pierga; Jean-Luc Raoul; J Provençal; Olivier Rixe; C Krisch; Caroline Germa; M Bekradda; Dominique Mignard; Mireille Mousseau
Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(22):4195-201.
2001: Yves Bécouarn; Marie-Pierre Blanc-Vincent; Michel Ducreux; P Lasser; Jean-Bernard Dubois; M Giovannini; Philippe Rougier
Cancer of the rectum.
British journal of cancer 2001;84 Suppl 2():69-73.
1998: Yves Bécouarn; Marc Ychou; Michel Ducreux; C Borel; Frédérique Bertheault-Cvitkovic; Jean-François Seitz; Salvador Nasca; T D Nguyen; Bernard Paillot; Jean-Luc Raoul; Jacqueline Duffour; A Fandi; G Dupont-André; Philippe Rougier
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2739-44.
1998: S Ollivier; Marianne Fonck; Yves Bécouarn; René Brunet
Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial.
American journal of clinical oncology 1998;21(3):237-40.
1997: Emmanuel Bussières; Jean-Bernard Dubois; L Demange; Martine Delannes; Pierre Richaud; Yves Bécouarn
IORT: a randomized trial in primary rectal cancer by the French group of IORT.
Frontiers of radiation therapy and oncology 1997;31():217-20.
1996: Yves Bécouarn; J F Seitz; H Perrier; M L Rouhier; M Giovannini; René Brunet
[Immunotherapy of colorectal cancers].
Gastroentérologie clinique et biologique 1996;20(1):20-32.
1995: Yves Bécouarn; René Brunet; M L Rouhier; Emmanuel Bussières; Antoine Avril; Pierre Richaud; J M Dilhuydy
High dose folinic acid and 5-fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer.
Cancer 1995;76(7):1126-31.
1993: Jean-Marie Dilhuydy; Philippe Lagarde; A S Allal; Yves Bécouarn; Pierre Soubeyran; Pierre Richaud; Alain Faucher; L Traissac; D Stoll
Ethmoidal cancers: a retrospective study of 22 cases.
International journal of radiation oncology, biology, physics 1993;25(1):113-6.
1992: F Zerbib; Yves Bécouarn; E Stöckle; Alain Ravaud; René Brunet
Colonic metastasis of a renal carcinoma. A case report.
Tumori 1992;78(3):219-20.
1992: Yves Bécouarn; René Brunet; Alain Ravaud; Emmanuel Bussières; Philippe Lagarde
[Systemic chemotherapy in metastatic colorectal adenocarcinomas].
Gastroentérologie clinique et biologique 1992;16(2):166-76.
1992: Béatrice Barreau; Marie-Hélène Dilhuydy; M Trojani; B Parsi; Emmanuel Bussières; Michèle Kind; A Le Treut; René Brunet; Yves Bécouarn; F Audat
[Extramammary carcinoid tumor metastatic to the breast. Apropos of a case].
Bulletin du cancer 1992;79(1):91-100.
1992: Fabrice Lakdja; A Lobera; Alain Faucher; JL Renaud-Salis; Yves Bécouarn; Alain Ravaud
[Symptomatic treatment of pain in cervico-facial cancers].
Revue de laryngologie - otologie - rhinologie 1992;113(3):165-71.
1991: Alain Ravaud; Sylvie Negrier; Fabrice Lakdja; A Mercatello; Laurent Cany; B Coronel; J Y Ranchere; Yves Bécouarn; Binh Nguyen Bui; T Philip
[Adverse effects of interleukin 2].
Bulletin du cancer 1991;78(11):989-1005.
1991: Alain Ravaud; Bernard Hoerni; Yves Bécouarn; Philippe Lagarde; Pierre Soubeyran; Françoise Bonichon
A survey in general practice about undergraduate cancer education: results from Gironde (France).
Journal of cancer education : the official journal of the American Association for Cancer Education 1991;6(3):153-7.
1991: Yves Bécouarn; Bernard Hoerni; Jean-Marie Dilhuydy; E Stöckle; C Bonneteau; René Brunet
[Modification of taste in cancer patients].
Bulletin du cancer 1991;78(10):901-13.
1991: Yves Bécouarn; Binh Nguyen Bui; René Brunet; Alain Ravaud
Cancer chemotherapy in the elderly: a series of 51 patients aged greater than 70 years.
Cancer chemotherapy and pharmacology 1991;29(2):159-63.
1990: Jean Chauvergne; L Mauriac; M Durand; M David; Alain Ravaud; Yves Bécouarn
[Relay chemotherapy using continuous perfusion of cisplatin and fluoro-uracil in advanced cancer of the breast. Analysis of a series of 50 cases].
Revue française de gynécologie et d'obstétrique 1990;85(4):211-9.
1989: Yves Bécouarn; René Brunet; C Barbé-Gaston
Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primary.
European journal of cancer & clinical oncology 1989;25(5):861-5.
1986: Yves Bécouarn; B B Nguyen; M David; Fabrice Lakdja; René Brunet; Jean Chauvergne
Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial.
European journal of cancer & clinical oncology 1986;22(12):1421-4.